We are live on ! Find out more
AICPI

ABG Innovation Capital Partners III Portfolio holdings

AUM $64.5K
1-Year Est. Return 1.01%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+1.01%
3 Year Est. Return
+5.56%
5 Year Est. Return
-85.52%
10 Year Est. Return
–
AUM
$832K
AUM Growth
-$67.9K
Cap. Flow
-$67.9K
Cap. Flow %
-8.16%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CSTL icon
Castle Biosciences
CSTL
+$67.9K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSTL icon
1
Castle Biosciences
CSTL
$929M
$745K 89.54%
33,626
-3,121
-8% -$67.9K
WHWK
2
Whitehawk Therapeutics
WHWK
$201M
$62.4K 7.5%
26,666
– –
SYBX
3
DELISTED
Synlogic
SYBX
$24.6K 2.95%
13,727
– –

Similar funds

FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
SNN
Shen Neil Nanpeng $36.3K AUM 179.45% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
MI
Motiv8 Investments Port St. Lucie, Florida $183K AUM 15.06% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
NA
Newport Asia San Francisco, California $2.21M AUM
IVSFI
IA Venture Strategies Fund II New York $4.08M AUM 174.71% 1-Year Est. Return

ABG Innovation Capital Partners III's Q1 2024 Portfolio in Review

As of Q1 2024, ABG Innovation Capital Partners III held 3 positions worth $832K, down 7.6% from $900K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ABG Innovation Capital Partners III withdrew a net $67.9K in Q1 2024, reducing 1 holding. Its largest reduction was Castle Biosciences, cutting an estimated $67.9K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG Innovation Capital Partners III's biggest Q1 2024 reduction was Castle Biosciences, cutting an estimated $67.9K.
  • ABG Innovation Capital Partners III's ten largest holdings make up 100% of its $832K portfolio in Q1 2024.
  • ABG Innovation Capital Partners III opened 0 new positions and closed 0 in Q1 2024.
  • ABG Innovation Capital Partners III's portfolio value fell 7.6% quarter-over-quarter to $832K.

Based on ABG Innovation Capital Partners III's 13F filing for Q1 2024, filed 15 May 2024.